High Purity Pregabalin CAS 148553-50-8 from China Suppliers and Factory - Safe Delivery Available
Tetracaine Specification
Pregabalin is a second- generation antiepileptic drug (AED) known with the proprietary brand name of Lyrica® (Pfizer, Tadworth) in the UK and USA (Pfizer, New York, NY).
Pregabalin (Lyrica), a derivative of GABA that is closely related to gabapentin, has undergone extensive research for its efficacy in treating conditions such as generalized anxiety disorder (GAD), fibromyalgia, neuropathic pain, and partial complex seizures. It seems to have a more targeted effect on the a2-δ subunit of calcium channels in the brain compared to gabapentin. Pregabalin was granted FDA approval at the end of 2004 for the treatment of neuropathic pain and epilepsy. In 2008, it became the first medication approved for the management of fibromyalgia. Although pregabalin was approved for GAD treatment in the European Union in 2006, it has not yet received FDA approval for GAD in the United States as of the time of writing.
Pregabalin, marketed as the anticonvulsant drug Lyrica, is used in the treatment of epilepsy and generalized anxiety disorder. Along with other anticonvulsants such as gabapentin and levetiracetam, pregabalin is also used to treat neuropathic pain. This certified reference standard is suitable for pregabalin GC/MS or LC/MS applications from forensic analysis, clinical toxicology and pain prescription monitoring to urine drug testing.
TETRACAINE HCL APPLICATIONS
S-Enantiomer of Pregabalin. A GABA analogue used as an anticonvulsant. Anxiolytic analgesic used to treat peripheral neuropathic pain and fibromyalgia.
Pregabalin is an anticonvulsant drug used for neuropathic pain, as an adjunct therapy for partial seizures, and in generalized anxiety disorder. It was designed as a more potent successor to gabapentin.
Pregabalin is used to treat epilepsy and anxiety. It’s also taken to treat nerve pain. Nerve pain can be caused by different conditions including diabetes and shingles, or an injury.
details
Frequently Asked Questions
Pregabalin is a second-generation antiepileptic drug (AED) commonly known by the proprietary brand name Lyrica®.
Pregabalin is used to treat conditions such as epilepsy, generalized anxiety disorder (GAD), fibromyalgia, neuropathic pain, and partial complex seizures.
Pregabalin is designed as a more potent successor to gabapentin and appears to have a more targeted effect on the a2-δ subunit of calcium channels in the brain.
Although Pregabalin was approved for the treatment of GAD in the European Union in 2006, it has not yet received FDA approval for GAD in the United States.
This certified reference standard is suitable for Pregabalin GC/MS or LC/MS applications, including forensic analysis, clinical toxicology, pain prescription monitoring, and urine drug testing.